(Q46430615)

22 December 2017

title

Effects of short-term alendronate on bone mineral density in haemodialysis patients (English)

1 reference

22 December 2017

1 reference

James B Wetmore

1

1 reference

22 December 2017

Leslie Z Benet

series ordinal

2

1 reference

22 December 2017

Danja Kleinstuck

series ordinal

3

1 reference

22 December 2017

Lynda Frassetto

series ordinal

4

1 reference

22 December 2017

publication date

1 August 2005

1 reference

22 December 2017

published in

Nephrology

1 reference

22 December 2017

volume

10

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

393-399

1 reference

22 December 2017

Prediction of postmenopausal fracture risk with use of bone mineral measurements.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Risk factors for hip fracture in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Bone mineral density thresholds for pharmacological intervention to prevent fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Discrepancy in results between spine and hip scans of a woman with end stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Official positions of the international society for clinical densitometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Two new regions of interest to evaluate separately cortical and trabecular BMD in the proximal femur using DXA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Bone mass and structure at the hip in men and women over the age of 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

Proximal femur geometry to detect and distinguish femoral neck fractures from trochanteric fractures in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00436.X

10.1111/J.1440-1797.2005.00436.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017